Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

• Rudick RA, 2008. Multiple sclerosis therapeutics: opportunities, strategies and challenges. Therapy, 5(5), pp.585-587. View at Publisher | View at Google Scholar | View at Indexing
• Kuchma BP, Briko NN. HYGIENIC JUSTIFICATION FOR IMPROVING THE PREVENTION OF INFECTIOUS DISEASES IN CHILDREN IN EDUCATIONAL INSTITUTIONS OF MOSCOW. View at Publisher | View at Google Scholar | View at Indexing
• Franco EL, Paavonen J. Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention. Clinical Practice. 2008 May 1;5(3):261. View at Publisher | View at Google Scholar | View at Indexing
• Sarkola M. Human papillomavirus (HPV) in mothers before and after delivery–a three year follow-up study. View at Publisher | View at Google Scholar | View at Indexing
•  Sarkola M. HUMAN PAPILLOMAVIRUS (HPV) IN MOTHERS BEFORE AND AFTER DELIVERY. View at Publisher | View at Google Scholar | View at Indexing
• Louvanto K. Outcomes of cervical human papillomavirus (HPV) infections among mothers in the Finnish Family HPV Study. View at Publisher | View at Google Scholar | View at Indexing
• WHEN DA. PRM63. View at Publisher | View at Google Scholar | View at Indexing
• Murillo R, Molano M, Martínez G, Mejía JC, Gamboa O. Research Article HPV Prevalence in Colombian Women with Cervical Cancer: Implications for Vaccination in a Developing Country. View at Publisher | View at Google Scholar | View at Indexing
• Healy D. The First Vaccine Wars. View at Publisher | View at Google Scholar | View at Indexing
• Archives T, Denmark TV. THE HPV VACCINE: WHY IS IT CONTROVERSIAL?. View at Publisher | View at Google Scholar | View at Indexing
• Scharl A, Goehring UJ. HPV vaccination. InDie Gynäkologie 2013 (pp. 365-376). Springer, Berlin, Heidelberg. View at Publisher | View at Google Scholar | View at Indexing
• Buchkova TN, Zryachkin NI. Clinical-epidemiological and pharmacoeconomic substantiation of the regional calendar of preventive vaccinations in the Saratov region. Epidemiology and vaccine prevention. 2013 (6 (73)). View at Publisher | View at Google Scholar | View at Indexing
•  Straw MJ. Current data on HPV vaccination. Pediatrics for practice. 2011 Sep 2; 12 (4): 258-60. View at Publisher | View at Google Scholar | View at Indexing
• Moutinho J. Human papillomavirus and lower genital tract intraepithelial lesions. Gynecology Manual. Lisbon: Permanyer. 2011:215-4. View at Publisher | View at Google Scholar | View at Indexing
• Li Weiwei, He Xiuping, Guo Xuena, Zhang Zhenying, Zhang Borun. Optimized expression of human papillomavirus 16 subtype L1 protein in Hansenula polymorpha. Chinese Journal of Bioengineering. 2009(10):1516-23. View at Publisher | View at Google Scholar | View at Indexing
• Sláma J. Vaccination against HPV. Clinical pharmacology and pharmacy. 2009 Jan 1; 22 (4): 153-5. View at Publisher | View at Google Scholar | View at Indexing
• De Carvalho NS. Cervical cancer vaccination: the real meaning of cross-protection and its impact on the prevention. Vaccine. 2008 Nov 25;26(50):6293-4. View at Publisher | View at Google Scholar | View at Indexing
• Baranov AA, Tatochenko VK, Namazova-Baranova LS. Achievements and problems of immunization. Bulletin of the Russian Academy of Medical Sciences. 2011 (6): 21-7. View at Publisher | View at Google Scholar | View at Indexing
• Rosa MI, Medeiros LR, Rosa DD, Bozzeti MC, Silva FR, Silva BR. Human papillomavirus and cervical neoplasia. Cadernos de saude publica. 2009 May; 25 (5): 953-64. View at Publisher | View at Google Scholar | View at Indexing
• Celewicz A, Celewicz M, W??owska M, Chudecka-G?az A, Menkiszak J, Urasi?ska E. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer. Polish Journal of Pathology. 2018;69(1):42. View at Publisher | View at Google Scholar | View at Indexing
• Rhee JE, Shin MY, Kim CM, Kee HY, Chung JK, Min SK, Kim SJ, Jang DH, Kim SS, Choi BS. Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development. Virology journal. 2010 Dec;7(1):1-4. View at Publisher | View at Google Scholar | View at Indexing
• Rhee JE, Shin MY, Kim CM, Kee HY, Chung JK, Min SK, Kim SJ, Jang DH, Kim SS, Choi BS. Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development. Virology journal. 2010 Dec;7(1):1-4. View at Publisher | View at Google Scholar | View at Indexing
• Rosa MI, Medeiros LR, Rosa DD, Bozzeti MC, Silva FR, Silva BR. Papilomavírus humano e neoplasia cervical. Cadernos de Saúde Pública. 2009;25:953-64. View at Publisher | View at Google Scholar | View at Indexing
• Murillo R, Molano M, Martínez G, Mejía JC, Gamboa O. HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country. Infectious Diseases in Obstetrics and Gynecology. 2009 Dec 20;2009. View at Publisher | View at Google Scholar | View at Indexing
• Basu P, Chowdhury D. Cervical cancer screening & HPV vaccination: a comprehensive approach to cervical cancer control. Indian Journal of Medical Research. 2009 Sep 1;130(3):241. View at Publisher | View at Google Scholar | View at Indexing
• Piras F, Piga M, De Montis A, Zannou AR, Minerba L, Perra MT, Murtas D, Atzori M, Pittau M, Maxia C, Sirigu P. Prevalence of human papillomavirus infection in women in Benin, West Africa. Virology journal. 2011 Dec;8(1):1-7. View at Publisher | View at Google Scholar | View at Indexing
• Schwarz TF. Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®. Advances in therapy. 2009 Nov;26(11):983-98. View at Publisher | View at Google Scholar | View at Indexing
• Einstein MH, Baron M, Levin MJ, Chatterjee A, Edwards RP, Zepp F, Carletti I, Dessy FJ, Trofa AF, Schuind A, Dubin G. Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years. Human vaccines. 2009 Oct 1;5(10):705-19. View at Publisher | View at Google Scholar | View at Indexing
• Samara KD, Antoniou KM, Karagiannis K, Margaritopoulos G, Lasithiotaki I, et al. 2012. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. International journal of oncology, 40(5), p.1397. View at Publisher | View at Google Scholar | View at Indexing
• Vadasz Z, Haj T, Halasz K, Rosner I, Slobodin G, et al. 2012. Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus. Arthritis research & therapy, 14(3), p.R146. View at Publisher | View at Google Scholar | View at Indexing
• Bolon B, 2012. Cellular and molecular mechanisms of autoimmune disease. Toxicologic pathology, 40(2), pp.216-229. View at Publisher | View at Google Scholar | View at Indexing
• Yin S and Gao B, 2010. Toll-like receptor 3 in liver diseases. Gastroenterology research and practice, 2010. View at Publisher | View at Google Scholar | View at Indexing
• Creasy BM and McCoy KL, 2011. Cytokines regulate cysteine cathepsins during TLR responses. Cellular immunology, 267(1), pp.56-66. View at Publisher | View at Google Scholar | View at Indexing
• Ren X, Zhou H, Li B and Su SB, 2011. Toll-like receptor 3 ligand polyinosinic: polycytidylic acid enhances autoimmune disease in a retinal autoimmunity model. International immunopharmacology, 11(6), pp.769-773. View at Publisher | View at Google Scholar | View at Indexing
• Molad Y, Pokroy-Shapira E and Carmon V, 2013. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding. Innate immunity, 19(6), pp.623-630. View at Publisher | View at Google Scholar | View at Indexing
• Nellimarla S and Mossman KL, 2014. Extracellular dsRNA: its function and mechanism of cellular uptake. Journal of Interferon & Cytokine Research, 34(6), pp.419-426. View at Publisher | View at Google Scholar | View at Indexing
• Yu H, Wang Z, Sun G and Yu Y, 2012. Recognition of nucleic acid ligands by toll-like receptors 7/8: importance of chemical modification. Current medicinal chemistry, 19(9), pp.1365-1377. View at Publisher | View at Google Scholar | View at Indexing

• Reimer E, Somplatzki S, Zegenhagen D, Hänel S, Fels A, et al. 2013. Molecular cloning and characterization of a novel anti-TLR9 intrabody. Cellular and Molecular Biology Letters, 18(3), pp.433-446.

  View at Publisher | View at Google Scholar
• Canas CA and Cañas F, 2012. The biological significance of evolution in autoimmune phenomena. Autoimmune diseases, 2012. View at Publisher | View at Google Scholar | View at Indexing
• Vadasz Z and Toubi E, 2012. Semaphorin 3A–a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus. Lupus, 21(12), pp.1266-1270. View at Publisher | View at Google Scholar | View at Indexing

• Abaturov AE, Volosovets AP and Yulish EI, 2013. THE ROLE OF NOD-SIMILAR RECEPTORS IN THE RECOGNITION OF PATHOGEN-ASSOCIATED MOLECULAR STRUCTURES OF INFECTIOUS PATHOGENIC AGENTS AND DEVELOPMENT OF INFLAMMATION OF PARTICLES 3B. NLR PROTEINS OF THE FAMILY PARTICIPATING IN THE ACTIVATION OF THE ASC-ASSOCIATED ROUTE OF EXCITATION. INFLAMMAS. Child's health, (4 (47)).

  View at Publisher | View at Google Scholar
• Stewart EA, Wei R, Branch MJ, Sidney LE and Amoaku WM, 2015. Expression of Toll-like receptors in human retinal and choroidal vascular endothelial cells. Experimental eye research, 138, pp.114-123. View at Publisher | View at Google Scholar | View at Indexing

• Shimizu S, Kurashige Y, Nishimura M, Yamazaki M, Sato J, et al. 2012. Involvement of toll‐like receptors in autoimmune sialoadenitis of the non‐obese diabetic mouse. Journal of Oral Pathology & Medicine, 41(7), pp.517-523.

  View at Publisher | View at Google Scholar
• Wang J, Qin Y and Mi X, 2016. The protective effects of bone marrow-derived mesenchymal stem cell (BMSC) on LPS-induced acute lung injury via TLR3-mediated IFNs, MAPK and NF-κB signaling pathways. Biomedicine & Pharmacotherapy, 79, pp.176-187. View at Publisher | View at Google Scholar | View at Indexing
• Cañas CA, 2011. Autoimmunity and autoinflammation. Acta Médica Colombiana, 36 (2), pp. 78-84. View at Publisher | View at Google Scholar | View at Indexing

• Amoaku WM, 2015. Expression of Toll-like receptors in human retinal and choroidal vascular endothelial cells. Experimental Eye Research, 30(1), p.e10.

  View at Publisher | View at Google Scholar
• Kaur G, Mohindra K and Singla S, 2017. Autoimmunity—Basics and link with periodontal disease. Autoimmunity Reviews, 16(1), pp.64-71. View at Publisher | View at Google Scholar | View at Indexing
• Paradowska-Gorycka A, 2015. U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue disease Part II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease. Reumatologia, 53(3), pp.143-151. View at Publisher | View at Google Scholar | View at Indexing
• Pandey G, Pandey AK, Pandey SS and Pandey BL, Microbiota in Immune Pathogenesis and the Prospects for Pre and Probiotic Dietetics in Psoriasis. Biomedical Research Journal, p.220. View at Publisher | View at Google Scholar | View at Indexing

• AAAOODIA, 2013. The role of RIG-like receptors in the recombination of pathogen-associated molecular structures of infectious pathogenic agents and inflammation. Part 1. FAMILY OF RLR.

  View at Publisher | View at Google Scholar